Invention Grant
- Patent Title: Chemokine receptor binding compounds
- Patent Title (中): 趋化因子受体结合化合物
-
Application No.: US11453221Application Date: 2006-06-14
-
Publication No.: US07790747B2Publication Date: 2010-09-07
- Inventor: Yuanxi Zhou , Elyse Bourque , Yongbao Zhu , Jonathan Langille , Markus Metz , Wen Yang , Ernest J. McEachern , Curtis Harwig , Ian R. Baird , Tong-Shuang Li , Renato T. Skerlj
- Applicant: Yuanxi Zhou , Elyse Bourque , Yongbao Zhu , Jonathan Langille , Markus Metz , Wen Yang , Ernest J. McEachern , Curtis Harwig , Ian R. Baird , Tong-Shuang Li , Renato T. Skerlj
- Applicant Address: US MA Cambridge
- Assignee: Genzyme Corporation
- Current Assignee: Genzyme Corporation
- Current Assignee Address: US MA Cambridge
- Agency: Morrison & Foerster LLP
- Main IPC: A61K31/4545
- IPC: A61K31/4545 ; C07D409/14
Abstract:
The present invention relates to chemokine receptor binding compounds, pharmaceutical compositions and their use. More specifically, the present invention relates to modulators of chemokine receptor activity, preferably modulators of CCR5. These compounds demonstrate protective effects against infection of target cells by a human immunodeficiency virus (HIV).
Public/Granted literature
- US20090099205A1 Chemokine receptor binding compounds Public/Granted day:2009-04-16
Information query
IPC分类:
